Very Low-Dose Direct Oral Anticoagulants Combined With Platelet Inhibitors in Coronary Artery Disease: Ready for Widespread Use?

Cardiovascular Medicine
doi 10.4414/cvm.2019.02062
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EMH Swiss Medical Publishers, Ltd.

Related search

Direct Oral Anticoagulants (DOACs)

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2015English

Usefulness of Direct Oral Anticoagulants in Adult Congenital Heart Disease

American Journal of Cardiology
Cardiovascular MedicineCardiology
2016English

Bleeding and Thrombotic Outcomes Associated With Postoperative Use of Direct Oral Anticoagulants After Open Peripheral Artery Bypass Procedures

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Aspirin Use Is Low Among United States Outpatients With Coronary Artery Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Novel Oral Anticoagulants for Acute Coronary Syndrome

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2016English

Real World Experience at a Single Centre Using Low Dose Direct Oral Anticoagulants After Unprovoked Venous Thromboembolism

British Journal of Haematology
Hematology
2019English

Direct Oral Anticoagulants: First Airbag

Medical Council
2019English

Hyperuricemia and Cardiovascular Diseases in Very Elderly Patients With Coronary Artery Disease

SN Comprehensive Clinical Medicine
2019English

Reversal Agents for Use With Direct and Indirect Anticoagulants

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy